ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/26 | 2,136 | 2,150 | 2,130 | 2,133 | -3 | -0.1% | 36,800 |
2022/08/25 | 2,147 | 2,153 | 2,136 | 2,136 | -1 | ±0% | 33,300 |
2022/08/24 | 2,139 | 2,147 | 2,122 | 2,137 | -10 | -0.5% | 46,900 |
2022/08/23 | 2,144 | 2,162 | 2,129 | 2,147 | -19 | -0.9% | 37,700 |
2022/08/22 | 2,138 | 2,166 | 2,127 | 2,166 | +19 | +0.9% | 29,000 |
2022/08/19 | 2,152 | 2,160 | 2,140 | 2,147 | +5 | +0.2% | 33,300 |
2022/08/18 | 2,171 | 2,173 | 2,134 | 2,142 | -38 | -1.7% | 58,400 |
2022/08/17 | 2,199 | 2,199 | 2,163 | 2,180 | +4 | +0.2% | 49,600 |
2022/08/16 | 2,184 | 2,191 | 2,165 | 2,176 | -7 | -0.3% | 46,300 |
2022/08/15 | 2,180 | 2,185 | 2,156 | 2,183 | +36 | +1.7% | 64,600 |
2022/08/12 | 2,116 | 2,173 | 2,116 | 2,147 | +25 | +1.2% | 66,400 |
2022/08/10 | 2,113 | 2,138 | 2,089 | 2,122 | +34 | +1.6% | 85,200 |
2022/08/09 | 2,136 | 2,147 | 2,077 | 2,088 | -58 | -2.7% | 93,600 |
2022/08/08 | 2,157 | 2,181 | 2,118 | 2,146 | -2 | -0.1% | 64,600 |
2022/08/05 | 2,230 | 2,230 | 2,145 | 2,148 | +68 | +3.3% | 166,900 |
2022/08/04 | 2,087 | 2,089 | 2,055 | 2,080 | +9 | +0.4% | 64,400 |
2022/08/03 | 2,121 | 2,131 | 2,063 | 2,071 | -49 | -2.3% | 68,700 |
2022/08/02 | 2,164 | 2,171 | 2,111 | 2,120 | -62 | -2.8% | 57,200 |
2022/08/01 | 2,183 | 2,190 | 2,165 | 2,182 | -5 | -0.2% | 45,600 |
2022/07/29 | 2,228 | 2,228 | 2,179 | 2,187 | -41 | -1.8% | 62,800 |
2022/07/28 | 2,252 | 2,253 | 2,201 | 2,228 | -6 | -0.3% | 92,600 |
2022/07/27 | 2,240 | 2,250 | 2,234 | 2,234 | -7 | -0.3% | 35,900 |
2022/07/26 | 2,251 | 2,255 | 2,233 | 2,241 | -10 | -0.4% | 34,300 |
2022/07/25 | 2,264 | 2,268 | 2,247 | 2,251 | +8 | +0.4% | 43,000 |
2022/07/22 | 2,243 | 2,260 | 2,236 | 2,243 | ±0 | ±0% | 68,400 |
2022/07/21 | 2,220 | 2,245 | 2,211 | 2,243 | +8 | +0.4% | 36,400 |
2022/07/20 | 2,230 | 2,239 | 2,210 | 2,235 | +20 | +0.9% | 60,100 |
2022/07/19 | 2,222 | 2,222 | 2,191 | 2,215 | +1 | ±0% | 40,900 |
2022/07/15 | 2,216 | 2,226 | 2,189 | 2,214 | +16 | +0.7% | 59,700 |
2022/07/14 | 2,193 | 2,200 | 2,181 | 2,198 | +4 | +0.2% | 25,200 |
2022/07/13 | 2,220 | 2,232 | 2,194 | 2,194 | -26 | -1.2% | 27,300 |
2022/07/12 | 2,211 | 2,220 | 2,201 | 2,220 | -7 | -0.3% | 57,600 |
2022/07/11 | 2,200 | 2,239 | 2,200 | 2,227 | +47 | +2.2% | 82,000 |
2022/07/08 | 2,171 | 2,209 | 2,154 | 2,180 | +18 | +0.8% | 124,200 |
2022/07/07 | 2,152 | 2,174 | 2,145 | 2,162 | +26 | +1.2% | 57,700 |
2022/07/06 | 2,127 | 2,145 | 2,123 | 2,136 | -4 | -0.2% | 40,200 |
2022/07/05 | 2,161 | 2,173 | 2,137 | 2,140 | -16 | -0.7% | 33,000 |
2022/07/04 | 2,150 | 2,157 | 2,131 | 2,156 | +34 | +1.6% | 56,800 |
2022/07/01 | 2,132 | 2,149 | 2,111 | 2,122 | -23 | -1.1% | 89,300 |
2022/06/30 | 2,168 | 2,180 | 2,141 | 2,145 | -18 | -0.8% | 57,700 |
2022/06/29 | 2,146 | 2,176 | 2,123 | 2,163 | +12 | +0.6% | 267,400 |
2022/06/28 | 2,102 | 2,156 | 2,091 | 2,151 | +49 | +2.3% | 123,800 |
2022/06/27 | 2,111 | 2,118 | 2,083 | 2,102 | -3 | -0.1% | 50,800 |
2022/06/24 | 2,089 | 2,105 | 2,080 | 2,105 | +22 | +1.1% | 55,000 |
2022/06/23 | 2,080 | 2,099 | 2,074 | 2,083 | ±0 | ±0% | 52,000 |
2022/06/22 | 2,076 | 2,092 | 2,065 | 2,083 | +18 | +0.9% | 51,100 |
2022/06/21 | 2,077 | 2,082 | 2,056 | 2,065 | -15 | -0.7% | 96,700 |
2022/06/20 | 2,073 | 2,088 | 2,070 | 2,080 | +10 | +0.5% | 43,400 |
2022/06/17 | 2,072 | 2,082 | 2,054 | 2,070 | -6 | -0.3% | 52,900 |
2022/06/16 | 2,077 | 2,088 | 2,067 | 2,076 | +15 | +0.7% | 37,300 |
551~
600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム